We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Methods Compared for Chagas Disease Diagnosis

By LabMedica International staff writers
Posted on 08 Aug 2017
Chagas Disease (CD) is a chronic infectious disease caused by the protozoan flagellate Trypanosoma cruzi. More...
In endemic countries, CD is transmitted mainly through the contact with feces of different triatomine bugs. Due to increased migration, CD has become an international health problem.

CD presents itself in two phases: whereas the acute phase is dominated by unspecific or no symptoms at all, in the chronic phase cardiac and/or gastrointestinal symptoms can occur after a long asymptomatic interval. Reliable diagnosis of chronically infected people is crucial for prevention of non-vectorial transmission as well as treatment.

European scientists led by those at the Medical Center of the University of Munich (Germany) tested samples consisting of 50 human EDTA blood samples that were previously tested positive by enzyme-linked immunosorbent assay (ELISA), immunofluorescence antibody test (IFAT) and polymerase chain reaction (PCR) for T. cruzi in the Instituto de Salud Carlos III, (Madrid, Spain) during 2010–2013. This study compared four distinct PCR methods for detection of T. cruzi DNA for the use in well-equipped routine diagnostic laboratories.

The team chose two conventional and two real-time PCR methods for closer evaluation. DNA was extracted of T. cruzi-positive and negative patients' blood samples and cultured T. cruzi, T. rangeli as well as Leishmania spp. One conventional and two real-time PCR methods targeting a repetitive satellite-DNA sequence as well as one conventional PCR method targeting the variable region of the kDNA minicircle were compared for sensitivity, intra- and interassay precision, limit of detection, specificity and cross-reactivity. For two methods the Professional Standard thermal cycler was operated, and for the other methods, the CFX C1000 Real-Time thermal cycler was used.

The team found that out of the 50 previously positive tested samples by serology and PCR, 44 samples were detected by all four methods. One method detected T. cruzi in all 50 samples. Potentially cross reactive agents (L. tropica, L. donovani, L. infantum, L. braziliensis, L. major, T. rangeli and T. brucei) showed similar results in all four methods. The costs of consumables are significantly cheaper for conventional methods than for real-time methods. The price of the conventional methods was below EUR 1/test, while it is around EUR two and eight per test for the relay time methods. The study was published in the July 2017 edition of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Medical Center of the University of Munich
Instituto de Salud Carlos III


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.